• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

褪黑素激动剂引起的视网膜电图改变:一种理解该药物抗抑郁作用的新途径?

Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?

机构信息

Department of Educative Science, University of Catania, Catania, Italy.

Department of Neurology, San Paolo Hospital, Savona, Italy.

出版信息

Neuropsychiatr Dis Treat. 2014 May 20;10:907-14. doi: 10.2147/NDT.S63459. eCollection 2014.

DOI:10.2147/NDT.S63459
PMID:24899809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4038423/
Abstract

BACKGROUND

Agomelatine, the first melatonergic antidepressant, has been postulated to enhance the dopaminergic activity at the central nervous system by 5-hydroxytryptamine receptor type 2C (5-HT2C) antagonism, yet the impact of melatonergic agonism on this pathway is unclear. Previous studies employing simplified, yet reliable, proxy (retinal) measures of the central nervous system dopaminergic activity, namely the standard electroretinogram (ERG) technique, suggested a reduction of the dopaminergic activity of the main ERG parameter, the b-wave, by pure melatonin, notably a hormone devoid of any antidepressant activity. Therefore, the antidepressant effects of the melatonergic antidepressant drug agomelatine should be reflected by a differential b-wave trend at ERG versus the effect exerted by pure melatonin, which was eventually found to be due to a contrasting effect on central dopaminergic transmission between the two drugs.

OBJECTIVE AND METHODS

The aim of the present preliminary ERG study carried out on healthy volunteers (n=23) receiving agomelatine was to explore the impact of this antidepressant drug on b-wave amplitude and latency of cones in daylight conditions using standard ERG.

RESULTS

As postulated, agomelatine induced an enhancement of retinal dopaminergic activity, in contrast to what has been previously documented for melatonin.

CONCLUSION

Given the limits of this explorative study, especially the lack of a control group and that of a luminance response function to measure retinal sensitivity, further studies in clinical samples are recommended to allow more tenable conclusions about the potential role of ERG in discriminating between 5-HT antagonism and melatonergic (MT) agonism in relationship to the claimed antidepressant effect of agomelatine.

摘要

背景

阿戈美拉汀是第一种褪黑素能抗抑郁药,据推测,它通过 5-羟色胺受体 2C(5-HT2C)拮抗作用增强中枢神经系统的多巴胺活性,然而,褪黑素能激动剂对该途径的影响尚不清楚。先前的研究采用简化但可靠的中枢神经系统多巴胺活性替代(视网膜)测量方法,即标准视网膜电图(ERG)技术,表明纯褪黑素降低了主要 ERG 参数,即 b 波的多巴胺活性,特别是一种没有任何抗抑郁作用的激素。因此,褪黑素能抗抑郁药阿戈美拉汀的抗抑郁作用应该反映在 ERG 上的 b 波趋势与纯褪黑素的作用之间存在差异,最终发现这是由于两种药物对中枢多巴胺传递的对比作用所致。

目的和方法

本研究旨在探讨这种抗抑郁药对健康志愿者(n=23)在日光条件下视锥细胞 b 波振幅和潜伏期的影响,采用标准 ERG 进行初步 ERG 研究。

结果

正如预期的那样,阿戈美拉汀诱导了视网膜多巴胺活性的增强,与先前记录的褪黑素相反。

结论

鉴于这项探索性研究的局限性,特别是缺乏对照组和测量视网膜敏感性的亮度反应函数,建议在临床样本中进行进一步研究,以便更有把握地得出关于 ERG 在区分 5-HT 拮抗作用和褪黑素(MT)激动作用与阿戈美拉汀声称的抗抑郁作用之间的潜在作用的结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c49/4038423/f1b31be220f9/ndt-10-907Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c49/4038423/9b4fc81551b1/ndt-10-907Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c49/4038423/f1b31be220f9/ndt-10-907Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c49/4038423/9b4fc81551b1/ndt-10-907Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c49/4038423/f1b31be220f9/ndt-10-907Fig2.jpg

相似文献

1
Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?褪黑素激动剂引起的视网膜电图改变:一种理解该药物抗抑郁作用的新途径?
Neuropsychiatr Dis Treat. 2014 May 20;10:907-14. doi: 10.2147/NDT.S63459. eCollection 2014.
2
A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.系统、更新的抗抑郁药阿戈美拉汀综述,重点关注其对褪黑素能的调节。
Curr Neuropharmacol. 2010 Sep;8(3):287-304. doi: 10.2174/157015910792246227.
3
Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.阿戈美拉汀(一种褪黑素激动剂)治疗成人重性抑郁障碍的临床实用性的评价与更新。
Neuropsychiatr Dis Treat. 2009;5:563-76. doi: 10.2147/ndt.s5453. Epub 2009 Nov 16.
4
Agomelatine: a novel antidepressant.阿戈美拉汀:一种新型抗抑郁药。
Innov Clin Neurosci. 2011 Nov;8(11):10-4.
5
Role of melatonin, serotonin 2B, and serotonin 2C receptors in modulating the firing activity of rat dopamine neurons.褪黑素、5-羟色胺 2B 受体和 5-羟色胺 2C 受体在调节大鼠多巴胺神经元放电活动中的作用。
J Psychopharmacol. 2014 Feb;28(2):162-7. doi: 10.1177/0269881113510071. Epub 2013 Nov 4.
6
Therapeutic potential of melatonin agonists.褪黑素激动剂的治疗潜力。
Expert Rev Endocrinol Metab. 2008 Mar;3(2):269-279. doi: 10.1586/17446651.3.2.269.
7
Agomelatine strongly interacts with zwitterionic DPPC and charged DPPG membranes.阿戈美拉汀与两性离子二棕榈酰磷脂酰胆碱(DPPC)和带电荷的二棕榈酰磷脂酰甘油(DPPG)膜有强烈相互作用。
Biochim Biophys Acta. 2014 Nov;1838(11):2798-806. doi: 10.1016/j.bbamem.2014.07.025. Epub 2014 Aug 2.
8
The Antidepressant Agomelatine Improves Memory Deterioration and Upregulates CREB and BDNF Gene Expression Levels in Unpredictable Chronic Mild Stress (UCMS)-Exposed Mice.抗抑郁药阿戈美拉汀可改善不可预测的慢性轻度应激(UCMS)暴露小鼠的记忆衰退,并上调CREB和BDNF基因表达水平。
Drug Target Insights. 2014 Mar 5;8:11-21. doi: 10.4137/DTI.S13870. eCollection 2014.
9
Melatonergic drugs for therapeutic use in insomnia and sleep disturbances of mood disorders.用于治疗失眠和心境障碍睡眠障碍的褪黑素能药物。
CNS Neurol Disord Drug Targets. 2012 Mar;11(2):180-9. doi: 10.2174/187152712800269740.
10
Understanding the Mechanism of Antidepressant-Related Sexual Dysfunction: Inhibition of Tyrosine Hydroxylase in Dopaminergic Neurons after Treatment with Paroxetine but Not with Agomelatine in Male Rats.了解抗抑郁药相关性性功能障碍的机制:帕罗西汀而非阿戈美拉汀治疗雄性大鼠后对多巴胺能神经元中酪氨酸羟化酶的抑制作用。
J Clin Med. 2019 Jan 23;8(2):133. doi: 10.3390/jcm8020133.

引用本文的文献

1
Colour vision defects in schizophrenia spectrum disorders: A systematic review.精神分裂症谱系障碍中的色觉缺陷:一项系统综述。
Neurosci Appl. 2024 Feb 12;3:104046. doi: 10.1016/j.nsa.2024.104046. eCollection 2024.
2
Exploring the ElectroRetinoGraphy as a biomarker for predicting and monitoring therapeutic response to antidepressants in major depressive disorder: study protocol for the MESANTIDEP trial.探索视网膜电图作为预测和监测重度抑郁症患者对抗抑郁药治疗反应的生物标志物:MESANTIDEP试验的研究方案
Front Psychiatry. 2025 Apr 25;16:1501166. doi: 10.3389/fpsyt.2025.1501166. eCollection 2025.
3
Effects of medications on the human electroretinogram: A comprehensive review.

本文引用的文献

1
Role of melatonin, serotonin 2B, and serotonin 2C receptors in modulating the firing activity of rat dopamine neurons.褪黑素、5-羟色胺 2B 受体和 5-羟色胺 2C 受体在调节大鼠多巴胺神经元放电活动中的作用。
J Psychopharmacol. 2014 Feb;28(2):162-7. doi: 10.1177/0269881113510071. Epub 2013 Nov 4.
2
Serotonin 2C receptor antagonists induce fast-onset antidepressant effects.5-羟色胺 2C 受体拮抗剂诱导快速起效的抗抑郁作用。
Mol Psychiatry. 2014 Oct;19(10):1106-14. doi: 10.1038/mp.2013.144. Epub 2013 Oct 29.
3
The brain through the retina: the flash electroretinogram as a tool to investigate psychiatric disorders.
药物对人体视网膜电图的影响:一项全面综述。
Surv Ophthalmol. 2025 Apr 12. doi: 10.1016/j.survophthal.2025.04.003.
4
Molecular Regulation of the Melatonin Biosynthesis Pathway in Unipolar and Bipolar Depression.单相和双相抑郁症中褪黑素生物合成途径的分子调控
Front Pharmacol. 2021 Apr 26;12:666541. doi: 10.3389/fphar.2021.666541. eCollection 2021.
5
A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder.阿戈美拉汀与艾司西酞普兰治疗重度抑郁症的疗效和安全性比较研究
J Clin Diagn Res. 2015 Jun;9(6):VC05-VC08. doi: 10.7860/JCDR/2015/12371.6092. Epub 2015 Jun 1.
6
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.阿戈美拉汀超越边界:其在重度抑郁症以外疾病中疗效的当前证据。
Int J Mol Sci. 2015 Jan 5;16(1):1111-30. doi: 10.3390/ijms16011111.
大脑通过视网膜:闪光视网膜电图作为研究精神障碍的工具。
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:129-34. doi: 10.1016/j.pnpbp.2013.09.020. Epub 2013 Oct 10.
4
A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers.一篇关于重度抑郁症外周生物标志物的综述:炎症和氧化应激生物标志物的潜力。
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:102-11. doi: 10.1016/j.pnpbp.2013.09.017. Epub 2013 Oct 5.
5
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials.重新评估阿戈美拉汀的疗效和可接受性:已发表和未发表随机试验的系统评价和荟萃分析。
Br J Psychiatry. 2013 Sep;203(3):179-87. doi: 10.1192/bjp.bp.112.120196.
6
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes.慢性给予阿戈美拉汀或文拉法辛可减少海马突触小体去极化诱发的谷氨酸释放。
BMC Neurosci. 2013 Jul 29;14:75. doi: 10.1186/1471-2202-14-75.
7
The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.褪黑素能系统在情绪和焦虑障碍中的作用及阿戈美拉汀的角色:对临床实践的启示
Int J Mol Sci. 2013 Jun 13;14(6):12458-83. doi: 10.3390/ijms140612458.
8
Negative impact of melatonin ingestion on the photopic electroretinogram of dogs.褪黑素摄入对犬明视视网膜电图的负面影响。
Neurosci Lett. 2013 May 24;543:78-83. doi: 10.1016/j.neulet.2013.02.070. Epub 2013 Apr 2.
9
The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders.视网膜电图作为中枢多巴胺和 5-羟色胺的生物标志物:与精神疾病的潜在相关性。
Biol Psychiatry. 2014 Mar 15;75(6):479-86. doi: 10.1016/j.biopsych.2012.11.024. Epub 2013 Jan 7.
10
Role of melatonin in mood disorders and the antidepressant effects of agomelatine.褪黑素在心境障碍中的作用和阿戈美拉汀的抗抑郁作用。
Expert Opin Investig Drugs. 2012 Oct;21(10):1503-22. doi: 10.1517/13543784.2012.711314. Epub 2012 Aug 9.